Circulating tumor fraction analyses with ultra-low pass whole genome sequencing predict response to chemoradiation and recurrence in stage IV small cell carcinoma of the cervix: a longitudinal case study
View ORCID ProfileAta Abbas, Morgan Gruner, Jennifer Karohl, Peter G. Rose, Amy Joehlin-Price, Hussein Al-Sudani, Daniel Stover, Haider Mahdi
doi: https://doi.org/10.1101/2020.11.18.20233502
Ata Abbas
1Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH 44106
Morgan Gruner
2Division of Gynecologic Oncology; Obstetrics, Gynecology and Women’s Health Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195
Jennifer Karohl
2Division of Gynecologic Oncology; Obstetrics, Gynecology and Women’s Health Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195
Peter G. Rose
2Division of Gynecologic Oncology; Obstetrics, Gynecology and Women’s Health Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195
Amy Joehlin-Price
3Department of Anatomic Pathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195
Hussein Al-Sudani
4Department of Internal Medicine, Albert Einstein Healthcare Network, Philadelphia, PA 19403
Daniel Stover
5Division of Medical Oncology, The Stefanie Spielman Comprehensive Breast Center, The James Cancer Hospital and Solove Research Institute at The Ohio State University Wexner Medical Center, Columbus, OH
Haider Mahdi
2Division of Gynecologic Oncology; Obstetrics, Gynecology and Women’s Health Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195
6Translational Hematology Oncology Research Department, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195
7Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195
Article usage
Posted November 20, 2020.
Circulating tumor fraction analyses with ultra-low pass whole genome sequencing predict response to chemoradiation and recurrence in stage IV small cell carcinoma of the cervix: a longitudinal case study
Ata Abbas, Morgan Gruner, Jennifer Karohl, Peter G. Rose, Amy Joehlin-Price, Hussein Al-Sudani, Daniel Stover, Haider Mahdi
medRxiv 2020.11.18.20233502; doi: https://doi.org/10.1101/2020.11.18.20233502
Circulating tumor fraction analyses with ultra-low pass whole genome sequencing predict response to chemoradiation and recurrence in stage IV small cell carcinoma of the cervix: a longitudinal case study
Ata Abbas, Morgan Gruner, Jennifer Karohl, Peter G. Rose, Amy Joehlin-Price, Hussein Al-Sudani, Daniel Stover, Haider Mahdi
medRxiv 2020.11.18.20233502; doi: https://doi.org/10.1101/2020.11.18.20233502
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (680)
- Anesthesia (182)
- Cardiovascular Medicine (2692)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12326)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4164)
- Geriatric Medicine (392)
- Health Economics (688)
- Health Informatics (2702)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3947)
- Nursing (214)
- Nutrition (587)
- Oncology (2076)
- Ophthalmology (596)
- Orthopedics (244)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1133)
- Primary Care Research (462)
- Public and Global Health (6590)
- Radiology and Imaging (1428)
- Respiratory Medicine (877)
- Rheumatology (415)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)